Kimberley S. Mak, MD, MPH
Assistant Professor, Radiation Oncology
Biography
Kimberley S. Mak, MD, MPH, is an Assistant Professor of Radiation Oncology at the Boston University School of Medicine and its affiliate Boston Medical Center. She received her MPH from Harvard School of Public Health (2014), MD from Harvard Medical School (2010) and AB summa cum laude in Biochemical Sciences from Harvard College (2005). Dr. Mak completed an internship in Internal Medicine at Brigham and Women’s Hospital (2011), followed by residency in the Harvard Radiation Oncology Program (2015), training at Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Children’s Hospital of Boston, and Boston Medical Center. Dr. Mak has board certification in Radiation Oncology by the American Board of Radiology. She speaks English and Cantonese. Her specialties include thoracic, gastrointestinal, breast, and musculoskeletal malignancies. She leads the Cyberknife® radiosurgery program for thoracic and gastrointestinal malignancies.
Her research interests include patient-reported outcomes including quality of life; disparity outcomes research; translational research; intensity-modulated and image-guided radiotherapy; CyberKnife® stereotactic radiotherapy; and functional imaging in radiotherapy. She has training and experience in biostatistics, epidemiology, decision analysis, meta-analysis, clinical trial design, and molecular and cell biology laboratory work.
Other Positions
- Member, BU-BMC Cancer Center, Boston University
- Boston Medical Center
- VA Boston Healthcare System
Websites
Education
- Harvard Medical School, MD
- Harvard School of Public Health, MPH
- Harvard College, AB
Publications
- Published on 6/1/2021
Lau KHV, Hamlyn E, Williams TJ, Qureshi MM, Mak K, Mian A, Cervantes-Arslanian A, Zhu S, Takahashi C. The Effects of Video Instruction on Neuroscience Intensive Care Unit Nursing Skills in Case Presentations and Neurological Examinations. J Neurosci Nurs. 2021 Jun 01; 53(3):129-133. PMID: 33840806.
Read at: PubMed - Published on 5/22/2021
Annesi CA, Poulson M, Mak KS, Tapan U, Dechert TA, Litle VR, Suzuki K. The Impact of Residential Racial Segregation on Non-Small Cell Lung Cancer Treatment and Outcomes. Ann Thorac Surg. 2021 May 22. PMID: 34033745.
Read at: PubMed - Published on 3/1/2021
Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2021 Mar; 52(1):229-236. PMID: 32152823.
Read at: PubMed - Published on 2/8/2021
Qureshi MM, Oladeru OT, Lam CM, Dyer MA, Mak KS, Hirsch AE, Truong MT. Disparities in Laryngeal Cancer Treatment and Outcomes: An Analysis by Hospital Safety-Net Burden. Laryngoscope. 2021 06; 131(6):E1987-E1997. PMID: 33555062.
Read at: PubMed - Published on 9/16/2020
Moeller AR, Clancy PE, Qureshi MM, Guill JR, Dyer MA, Hirsch AE, Truong MT, Mak KS. Placard in Hand: A Simple, Inexpensive Intervention to Improve On-Treatment Visit Compliance in a Safety Net Radiation Oncology Patient Population. JCO Oncol Pract. 2020 11; 16(11):e1272-e1281. PMID: 32936711.
Read at: PubMed - Published on 6/10/2020
Yu S, Xu H, Sinclair A, Zhang X, Langner U, Mak K. Dosimetric and planning efficiency comparison for lung SBRT: CyberKnife vs VMAT vs knowledge-based VMAT. Med Dosim. 2020 Winter; 45(4):346-351. PMID: 32532613.
Read at: PubMed - Published on 12/19/2019
Asokan S, Sridhar P, Qureshi MM, Bhatt M, Truong MT, Suzuki K, Mak KS, Litle VR. Presentation, Treatment, and Outcomes of Vulnerable Populations With Esophageal Cancer Treated at a Safety-Net Hospital. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):347-354. PMID: 31866573.
Read at: PubMed - Published on 4/1/2019
Yan SX, Qureshi MM, Dyer M, Truong MT, Mak KS. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. Lung Cancer. 2019 05; 131:147-153. PMID: 31027693.
Read at: PubMed - Published on 12/31/2018
Sridhar P, Bhatt M, Qureshi MM, Asokan S, Truong MT, Suzuki K, Mak KS, Litle VR. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden. Ann Thorac Surg. 2019 05; 107(5):1472-1479. PMID: 30605641.
Read at: PubMed - Published on 7/24/2018
Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 10; 124:135-142. PMID: 30268452.
Read at: PubMed
View 20 more publications: View full profile at BUMC